Brainstorm Cell Therapeutics Inc. SEC filings BCLI
Brainstorm Cell Therapeutics Inc. has 949 filings in SEC EDGAR's recent list, going back to May 24, 2001. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 30, 2026 | Jul 24, 2026 |
| EFFECT | Filing | Jun 2, 2026 | — |
| CORRESP | Letter to the SEC | Jun 1, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 28, 2026 | May 25, 2026 |
| UPLOAD | Letter from the SEC | May 27, 2026 | — |
| S-8 | Employee stock plan registration | May 21, 2026 | — |
| S-1 | Registration statement | May 21, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Feb 27, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 13, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 9, 2026 | Jan 5, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Nov 14, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 6, 2025 | Oct 31, 2025 |
| 25-NSE | Delisting notice | Oct 9, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| RW | Filing | Jul 22, 2025 | — |
| 8-K |
Current report
Listing notice
|
Jul 17, 2025 | Jul 16, 2025 |
| S-8 | Employee stock plan registration | Jul 3, 2025 | — |
| S-3 | Shelf registration | Jun 25, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Other events
|
May 19, 2025 | May 19, 2025 |
| ARS | Annual report to shareholders | May 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 16, 2025 | — |
| DEF 14A | Proxy statement | May 16, 2025 | Jun 25, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| PRE 14A | Preliminary proxy statement | May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 21, 2025 | Apr 20, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 27, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 21, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 15, 2025 | Jan 15, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 30, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change
|
Oct 1, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| EFFECT | Filing | Sep 27, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 26, 2024 | Sep 26, 2024 |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| CORRESP | Letter to the SEC | Sep 24, 2024 | — |
| S-3/A | Form s-3/a | Sep 24, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2024 | — |
| S-3 | Shelf registration | Sep 17, 2024 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Sep 16, 2024 | Sep 16, 2024 |
| EFFECT | Filing | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 4, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2024 | — |
| S-3 | Shelf registration | Aug 28, 2024 | — |
| ARS | Annual report to shareholders | Aug 16, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Aug 16, 2024 | Sep 16, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| PRER14A | Filing | Aug 6, 2024 | — |
| PRE 14A | Preliminary proxy statement | Aug 5, 2024 | Sep 16, 2024 |
| 8-K | Current report | Jul 30, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 19, 2024 | Jul 18, 2024 |
| 424B5 | Prospectus supplement | Jun 28, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 28, 2024 | Jun 27, 2024 |
| 424B5 | Prospectus supplement | Jun 27, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 20, 2024 | Jun 19, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 4, 2024 | Jun 3, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Listing notice
|
May 3, 2024 | May 1, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 17, 2024 | Apr 16, 2024 |
| 8-K |
Current report
Other events
|
Apr 11, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Other events
|
Apr 9, 2024 | Apr 9, 2024 |
| 424B5 | Prospectus supplement | Apr 2, 2024 | — |
| 8-K |
Current report
Material agreement
|
Apr 2, 2024 | Apr 2, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure, Other events
|
Dec 20, 2023 | Dec 18, 2023 |
| DEFA14A | Additional proxy material | Nov 22, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 22, 2023 | Nov 20, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 9, 2023 | Nov 6, 2023 |
| DEF 14A | Proxy statement | Nov 8, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 3, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Oct 24, 2023 | Oct 18, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 19, 2023 | Jul 17, 2023 |
| 424B5 | Prospectus supplement | Jul 19, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Jun 20, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Officer or director change
|
May 24, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jan 11, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Jan 4, 2023 | Jan 3, 2023 |
| DEF 14A | Proxy statement | Dec 13, 2022 | Jan 10, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2022 | Oct 7, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Sep 22, 2022 | Sep 18, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2022 | Nov 15, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 17, 2021 | Dec 14, 2021 |
| S-8 | Employee stock plan registration | Dec 10, 2021 | — |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| DEF 14A | Proxy statement | Nov 4, 2021 | Dec 14, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2021 | Oct 27, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 25, 2021 | Aug 20, 2021 |
| EFFECT | Filing | Aug 19, 2021 | — |
| CORRESP | Letter to the SEC | Aug 17, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2021 | — |
| 8-K |
Current report
Agreement ended
|
Aug 13, 2021 | Aug 9, 2021 |
| S-3 | Shelf registration | Aug 9, 2021 | — |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change
|
May 28, 2021 | May 26, 2021 |
| 10-Q | Quarterly report | Apr 26, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 26, 2021 | Apr 26, 2021 |
| 10-K | Annual report | Feb 4, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2021 | Feb 4, 2021 |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Nov 12, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 27, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Results of operations
|
Oct 15, 2020 | Oct 15, 2020 |
| 10-Q | Quarterly report | Oct 15, 2020 | Sep 30, 2020 |
| DEF 14A | Proxy statement | Oct 1, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Material agreement
|
Sep 25, 2020 | Sep 25, 2020 |
| 424B5 | Prospectus supplement | Sep 25, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2020 | Sep 2, 2020 |
| 424B3 | Prospectus | Aug 7, 2020 | — |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 424B3 | Prospectus | Jun 26, 2020 | — |
| 424B3 | Prospectus | Jun 26, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2020 | Jun 23, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2020 | Apr 1, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 31, 2020 | Mar 30, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 13, 2020 | Mar 9, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 6, 2020 | Mar 6, 2020 |
| 424B5 | Prospectus supplement | Mar 6, 2020 | — |
| 8-K |
Current report
Material agreement
|
Mar 6, 2020 | Mar 6, 2020 |
| 424B5 | Prospectus supplement | Mar 6, 2020 | — |
| 10-K | Annual report | Feb 18, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Dec 11, 2019 | Dec 11, 2019 |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| DEF 14A | Proxy statement | Oct 25, 2019 | Dec 11, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2019 | Sep 5, 2019 |
| EFFECT | Filing | Aug 30, 2019 | — |
| 424B1 | Filing | Aug 30, 2019 | — |
| CORRESP | Letter to the SEC | Aug 28, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2019 | — |
| S-3 | Shelf registration | Aug 16, 2019 | — |
| 10-Q | Quarterly report | Aug 13, 2019 | Jun 30, 2019 |
| D | Filing | Aug 9, 2019 | — |
| 424B3 | Prospectus | Aug 2, 2019 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 2, 2019 | Aug 2, 2019 |
| 8-K |
Current report
Officer or director change
|
Jul 26, 2019 | Jul 23, 2019 |
| 8-K |
Current report
Material agreement
|
Jun 11, 2019 | Jun 11, 2019 |
| 424B5 | Prospectus supplement | Jun 11, 2019 | — |
| 8-K |
Current report
Other events
|
May 13, 2019 | May 13, 2019 |
| 10-Q | Quarterly report | May 10, 2019 | Mar 31, 2019 |
| 10-K/A | Amended annual report | Apr 1, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 29, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 12, 2019 | Mar 12, 2019 |
| S-8 | Employee stock plan registration | Dec 21, 2018 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 30, 2018 | Nov 29, 2018 |
| 10-Q | Quarterly report | Oct 29, 2018 | Sep 30, 2018 |
| DEF 14A | Proxy statement | Oct 10, 2018 | Nov 29, 2018 |
| EFFECT | Filing | Sep 28, 2018 | — |
| 424B1 | Filing | Sep 28, 2018 | — |
| CORRESP | Letter to the SEC | Sep 21, 2018 | — |
| S-3/A | Filing | Sep 21, 2018 | — |
| 10-Q | Quarterly report | Jul 23, 2018 | Jun 30, 2018 |
| UPLOAD | Letter from the SEC | Jul 6, 2018 | — |
| EFFECT | Filing | Jun 29, 2018 | — |
| S-3 | Shelf registration | Jun 29, 2018 | — |
| CORRESP | Letter to the SEC | Jun 27, 2018 | — |
| D | Filing | Jun 20, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2018 | — |
| S-3 | Shelf registration | Jun 8, 2018 | — |
| 424B3 | Prospectus | Jun 7, 2018 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 7, 2018 | Jun 6, 2018 |
| 10-Q | Quarterly report | May 14, 2018 | Mar 31, 2018 |
| 10-K | Annual report | Mar 8, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2018 | Feb 1, 2018 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCLI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1137883
- Former names
- BRAINSTORM CELL THERAPEUTICS INC (until Jul 23, 2012); GOLDEN HAND RESOURCES INC (until Nov 22, 2004); WIZBANG TECHNOLOGIES INC (until Aug 8, 2003)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.